Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Meningococcal Disease Vaccine Market?
The meningococcal disease vaccine market has experienced significant expansion in recent times. Projections indicate it will expand from $2.37 billion in 2024 to $2.59 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.4%. This historical increase is a result of enhanced vaccine manufacturing capabilities, worldwide health collaborations, the integration into national immunization programs, an increase in meningococcal disease incidences, and growing initiatives from various organizations.
The meningococcal disease vaccine market size is anticipated to undergo significant expansion over the forthcoming years, with projections indicating a rise to $3.75 billion by 2029, exhibiting a robust compound annual growth rate (CAGR) of 9.7%. This expected growth within the forecast period is primarily fueled by increasing recognition of preventive healthcare, the broadening of target age demographics, the introduction of new entities into the market, efforts by government and health agencies to stockpile vaccines for potential epidemics, and heightened public understanding. Furthermore, major developments predicted for this period include substantial progress in vaccine technology, such as the creation of multivalent, conjugate, and protein-based vaccines, evolving global travel and migration dynamics, intensified research and development into mRNA technology, and breakthroughs in thermostable formulations.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24317&type=smp
Which Major Market Drivers Are Shaping The Future Of The Meningococcal Disease Vaccine Market?
The expanding government immunization initiatives are anticipated to boost the growth of the meningococcal disease vaccine market moving forward. These government programs are health efforts designed to provide free or affordable vaccines, protecting communities from infectious diseases. The increase in government immunization programs is a result of a stronger focus on preventing infectious diseases and reducing healthcare burdens through widespread vaccination. These programs fuel the expansion of meningococcal vaccines by improving access and raising vaccination rates, simultaneously increasing awareness and decreasing disease occurrence. They also generate demand by making vaccinations mandatory and promoting public health. For example, in April 2024, the Pan American Health Organization (PAHO), a US-based specialized agency, launched the 22nd Vaccination Week in the Americas (VWA) with the theme ‘Engage now to protect your future. GetVax’. This initiative aimed to boost vaccination coverage, especially in underserved areas, by administering over 65 million doses. The effort concentrated on fighting misinformation and improving vaccine access through community involvement and customized campaigns. Thus, the growing government immunization programs are driving the expansion of the meningococcal disease vaccine market.
What Are The Major Segment Types Covered In The Meningococcal Disease Vaccine Market?
The meningococcal disease vaccinemarket covered in this report is segmented –
1) By Vaccine Type: Conjugate Vaccines; Polysaccharide Vaccines; Recombinant Vaccines; Live Attenuated Vaccines
2) By Age Group: Infants; Children; Adults; Older Adults
3) By Indication: Preventive Vaccination; Post-Exposure Prophylaxis; Travel-Related Vaccination; Outbreak Response
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Conjugate Vaccines: Monovalent Conjugate Vaccines; Quadrivalent Conjugate Vaccines; Pediatric Conjugate Vaccines; Adolescent Or Adult Conjugate Vaccines
2) By Polysaccharide Vaccines: Bivalent Polysaccharide Vaccines; Trivalent Polysaccharide Vaccines; Quadrivalent Polysaccharide Vaccines; Age-Specific Polysaccharide Formulations
3) By Recombinant Vaccines: Serogroup B Recombinant Protein Vaccines; Multicomponent Recombinant Vaccines; Outer Membrane Vesicle (OMV) Based Recombinant Vaccines
4) By Live Attenuated Vaccines: Experimental Intranasal Live Attenuated Vaccines; Genetically Engineered Attenuated Strain Vaccines; Combined Live Attenuated Vaccines
What Trends Are Redefining The Meningococcal Disease Vaccine Market Dynamics?
Leading companies operating within the meningococcal disease vaccine market are concentrating on the development of advanced solutions, such as pentavalent meningococcal vaccines, to broaden serogroup protection, optimize immunization schedules, and enhance disease prevention. A pentavalent meningococcal vaccine represents an advanced immunization method designed to target five principal serogroups of Neisseria meningitidis with a single administration, thereby reducing the necessity for multiple separate vaccinations and improving patient adherence. As an illustration, in October 2023, Pfizer Inc., a US-based biopharmaceutical entity, announced the Food and Drug Administration (FDA) approval for PENBRAYA, which stands as the premier and sole vaccine for preventing meningococcal disease in individuals aged 10 to 25 years. This innovative vaccine combines components from two existing meningococcal vaccines, Trumenba and Nimenrix, to safeguard against the five most prevalent serogroups (A, B, C, W, and Y) of Neisseria meningitidis that are responsible for the majority of invasive meningococcal disease (IMD) cases globally. PENBRAYA marks a substantial leap forward in meningococcal disease prevention, offering the most extensive serogroup coverage of any meningococcal vaccine accessible in the U.S. and potentially simplifying the vaccination regimen by decreasing the total doses needed for comprehensive protection.
Who Are The Key Multinational Companies Dominating The Meningococcal Disease Vaccine Market?
Major companies operating in the meningococcal disease vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi SA, Novartis AG, GlaxoSmithKline plc, Hualan Biological Engineering Inc., Beijing Tiantan Biological Products Corporation Limited, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Incepta Pharmaceuticals Ltd., CanSino Biologics Inc., EuBiologics Co. Ltd., Biovac Institute, Shantha Biotech, Bio-Manguinhos, Biomed Pvt. Ltd., Chengdu Kanghua Biological Products Co. Ltd., Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd., Finlay Institute of Vaccines, Immunopreparat.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/meningococcal-disease-vaccine-global-market-report
What Regional Growth Trends Are Shaping The Meningococcal Disease Vaccine Market Outlook?
North America was the largest region in the meningococcal disease vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the meningococcal disease vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Meningococcal Disease Vaccine Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24317&type=smp
Browse Through More Reports Similar to the Global Meningococcal Disease Vaccine Market 2025, By The Business Research Company
Veterinary Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Pediatric Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model